Vivalab SRL
2.6 FTEThe score of Vivalab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -34 % Total assets +539 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vivalab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Jul 2026
- Year ended 31 Dec 2024filed on 19 Sep 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Vivalab's financial analysis
- Solvency0.2%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vivalab
Vivalab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0451.073.259
- VAT number
- BE0451073259
- Peppol
- Registered · 0208:0451073259 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Oct 1993
- Registered office
- 6700 Arlon
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 21 Jul 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Vivalab (SRL) has been based in Arlon since 1993, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 274 € and equity of 6,197 €; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 0.2%, below the median of its sector (66.2%).
Companies similar to Vivalab
Companies in the same business, of comparable size and area, outside its group.
- Artsenpraktijk Sithova Diagnostic imaging services and medical laboratory activities Leuven · balance sheet €3.20m
- Apr. Boel A. Diagnostic imaging services and medical laboratory activities Merelbeke-Melle · balance sheet €2.31m
- DR. Sabine Vergauwen Diagnostic imaging services and medical laboratory activities Bornem · balance sheet €2.18m
- Willsint Diagnostic imaging services and medical laboratory activities Sint-Niklaas · balance sheet €2.06m
- Ghislain Dermatologie Diagnostic imaging services and medical laboratory activities Mons · balance sheet €1.99m
- Medisch Kabinet DR. JAN Laenens - Huisarts Diagnostic imaging services and medical laboratory activities Aarschot · balance sheet €1.71m
- Oncurious Diagnostic imaging services and medical laboratory activities Brussels · balance sheet 160,462 €
- Chrometra Diagnostic imaging services and medical laboratory activities Kortenaken · balance sheet 97,221 €
Frequently asked questions about Vivalab
What is the revenue of Vivalab?
Vivalab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vivalab?
In Belgium, the VAT number is the company number prefixed with BE: BE0451073259 for Vivalab, if the company is VAT-registered. Its company number (CBE) is 0451.073.259.
Where is the registered office of Vivalab?
According to the CBE register, the registered office of Vivalab is in 6700 Arlon.
What is the equity of Vivalab?
At the close of the 2025 financial year, the equity of Vivalab amounts to 6,197 €, a solvency of 0.2% of total assets.
How many people work at Vivalab?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Vivalab?
The register lists 2 active mandates at Vivalab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vivalab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →